Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells
- PMID: 4063977
Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells
Abstract
The effects of N-benzyladriamycin-14-valerate (AD198) and N,N-dimethyladriamycin-14-valerate (AD199), two novel lipophilic N-alkyl derivatives of Adriamycin (ADR), on cell growth and cell cycle distribution were investigated in L1210 cells grown in suspension. Following a 1-h exposure to the drug levels selected, growth inhibition was noticeable in all cultures for most or all of the observation period of 96 h. With flow cytometry, an asynchronous cell population was measured with respect to cellular DNA, RNA, and light scatter (size) properties following a 1-h incubation with the various ADR analogues. In addition, flow cytometric techniques were utilized to determine whether drug treatment altered the sensitivity of DNA in situ to acid-induced denaturation or to binding by small DNA-intercalating dyes. Unlike the parent compound ADR or its DNA-nonbinding derivative N-trifluoroacetyladriamycin-14-O-hemiadipate (AD143), the N-alkyl derivatives AD198 and AD199 only slightly affected L1210 cell cycle traverse over the first 5 h posttreatment. However, by 24 h, AD199 (0.62 micrograms/ml) caused an S- and G2 + M-phase accumulation which became more dramatic at 48 and 72 h. AD198 (3.27 micrograms/ml) also caused an accumulation of cells predominantly in G2 + M phase at longer culture times (48 to 96 h). The two half-substituted congeners N-benzyladriamycin (AD288) and N,N-dimethyladriamycin (AD280) affected L1210 cell cycle traverse over a similar time scale at concentrations of 12.3 and 4.17 micrograms/ml, respectively. AD280 blocked cells in G1 and G2 + M whereas AD288 caused predominantly a G2 + M accumulation. While neither ADR nor AD143 interfered appreciably with binding and fluorescence of the intercalating dye acridine orange, all of the N-alkyl analogues tested reduced the fluorescence signal of acridine orange-stained L1210 cells by 26 to 60%. This effect lasted, with decreasing intensity, for at least 48 h following a 1-h exposure to the drugs. In addition, while ADR appeared to stabilize DNA in situ against acid-induced denaturation, all N-alkyl derivatives, to varying degrees, tended to increase DNA denaturability. Thus alkylation at the glycoside amine combined with the lipophilic 14-valerate side chain function accounts for several new biochemical and biological properties of AD198 and AD199, relative to ADR.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.Cancer Res. 1981 Jul;41(7):2728-37. Cancer Res. 1981. PMID: 6166368
-
Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198.Cancer Res. 1991 Jul 15;51(14):3682-9. Cancer Res. 1991. PMID: 2065324
-
Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells.Cancer Res. 1980 Mar;40(3):671-81. Cancer Res. 1980. PMID: 6162553
-
Kinetics of cell kill by hyperthermia.Cancer Res. 1979 Jun;39(6 Pt 2):2277-84. Cancer Res. 1979. PMID: 376117 Review.
-
A study on structure-activity relationships of nucleoside analogues.Drugs Exp Clin Res. 1986;12(4):355-67. Drugs Exp Clin Res. 1986. PMID: 3013563 Review.
Cited by
-
Comparative uptake and retention of adriamycin and N-benzyladriamycin-14-valerate in human CEM leukemic lymphocyte cell cultures.Cancer Chemother Pharmacol. 1989;25(3):177-83. doi: 10.1007/BF00689579. Cancer Chemother Pharmacol. 1989. PMID: 2598408
-
Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells.Oncotarget. 2018 Jun 19;9(47):28514-28531. doi: 10.18632/oncotarget.25530. eCollection 2018 Jun 19. Oncotarget. 2018. PMID: 29983877 Free PMC article.
-
A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.Drug Des Devel Ther. 2015 Sep 25;9:5323-35. doi: 10.2147/DDDT.S90859. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26451087 Free PMC article.
-
Kinetic and survival response of the M14 cell line to lonidamine associated with adriamycin or hyperthermia.J Cancer Res Clin Oncol. 1987;113(5):451-8. doi: 10.1007/BF00390039. J Cancer Res Clin Oncol. 1987. PMID: 3624301 Free PMC article.
-
Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat.Cancer Chemother Pharmacol. 1996;37(5):472-8. doi: 10.1007/s002800050414. Cancer Chemother Pharmacol. 1996. PMID: 8599871
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials